Novel hypotheses emerging from GWAS in migraine?

Area of Science:

• Genetics
• Neurology
• Bioinformatics

Background:

• Recent advances in genetics enable large-scale genome-wide association studies (GWAS) for migraine.
• Over 40 common DNA sequence variants (SNPs) associated with migraine risk have been identified.
• Replication in independent studies confirms the robustness of these genetic associations.

Purpose of the Study:

• To provide an overview of GWAS findings in migraine.
• To discuss current hypotheses on migraine disease pathways derived from GWAS.
• To highlight the challenges and drawbacks in translating genetic findings to clinical use.

Main Methods:

• Review of findings from large-scale genome-wide association studies (GWAS) in migraine.
• Analysis of bioinformatic efforts to link migraine risk SNPs with genes and pathways.
• Discussion of the limitations of current approaches in gene and pathway identification.

Main Results:

• GWAS have identified numerous SNPs associated with various migraine types.
• Genetic data suggests involvement of vascular, neuronal, and other mechanisms (e.g., metal ion homeostasis, neuronal migration).
• Significant challenges exist in pinpointing causal genes and pathways using bioinformatics alone.

Conclusions:

• The complexity of migraine's genetic pathophysiology hinders clinical translation.
• Current bioinformatic approaches have limitations in identifying precise disease genes and pathways.
• Urgent need for increased functional research to bridge the gap between GWAS hypotheses and clinical utility in migraine management.